SLC29A1 and gastric cancer: A retrospective analysis of 111 patients with resected gastric cancer who had not received gemcitabine-based chemotherapy revealed that patients with high hENT1 expression had a shorter OS or DFS than those with low hENT1 expression (Santini et al., 2010).